ARCHIVES

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012